Проблемы и достижения генной терапии муковисцидоза

1. Anderson W.F. Human gene therapy. Nature 1998; 392: 25—30.

2. Baranov A., Glazkov P., Kiselev A. et al. Local and distant transfection of mdx muscle fibers with dystrophin and LacZ genes delivered in vivo by synthetic microspheres. Gene Ther. 1999; 6: 1406—1414.

3. Discher B.M., Won Y.Y., Ege D.S. et al. Polymersomes: tough vesicles made from diblock copolymers. Science 1999; 284: 1143—1146.

4. Dorin J.R., Dickinson P., Alton E.W. et al. Cystic fibrosis in the mouse by targeted insertional mutagenesis. Nature 1992; 359: 211—217.

5. Kay M.A., Liu D., Hoogerbrugge P.M. Gene therapy. Proc. Natl. Acad. Sci. USA 1997;. 94: 12744—12746.

6. Moelling K. Naked DNA—the poor man’s gene therapy? Gene Ther. 1998; 5: 571—572

7. Turner G., Dunckley М., Dicson G. Gene therapy of Duchenne muscular dystrophy. In: Brown S., Lucy J., eds. Dystrophin. Gene, protein and cell biology. Cambridge: Cambrigde Univ. Press; 1997. 275—309.

8. Zabner J.t Ramsey B.W., Meeker D.P. et al. Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis. J. Clin. Invest. 1996; 97: 1504—1511.